Hepatic safety also confirmed over six months of treatment with mealtime liver targeted insulin Company focused on Phase 3 initiation in 2020 CLEVELAND, June 10, 2019 (GLOBE NEWSWIRE) -- Diasome ...

PALO ALTO, Calif., Oct. 23, 2017 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc., (NASDAQ: EIGR) today announced positive interim 24-week data with pegylated interferon lambda (Lambda) in the Phase 2 ...

CLEVELAND, June 04, 2020 (GLOBE NEWSWIRE) -- Diasome Pharmaceuticals, Inc., a company developing hepatocyte directed vesicle (HDV) technology that can be added to any commercially available insulin to ...

An investigational liver-targeted formulation of fast-acting insulin may help minimize hypoglycemia in patients with poorly controlled type 1 diabetes, new research suggests. Findings regarding ...

iShares Core High Dividend ETF comprises 75 high-quality U.S. securities that pay above-average dividend yields and pass Morningstar's Economic Moat, Uncertainty, and Distance to Default screens. Its ...

iShares Core High Dividend ETF (HDV) is downgraded to Hold due to underperformance driven by heavy energy and healthcare sector exposure. HDV's high dividend yield is offset by sluggish price momentum ...

While some high-yield dividend ETFs offer massive yields that entice investors, their returns can be underwhelming over time. Investors may receive a large dividend payout from these ETFs, but the ...

BEIJING and GOTHENBURG, Sweden, Oct. 24, 2025 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB (Ribo), today announced that the European Medicines Agency (EMA) has ...

The iShares Core High Dividend ETF (NYSEARCA:HDV) and the Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) are two popular dividend ETFs from blue-chip sponsors. Both are cost-effective options with ...

Panel A shows the structure of HDV, which shares the hepatitis B surface antigen (HBsAg) envelope with hepatitis B virus. The virion contains a single-stranded, circular RNA genome of approximately ...